Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 49.05
+0.35 (0.72%)
At close: Nov 28, 2025
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 602.71 million as of November 28, 2025. Its market cap has increased by 20.69% in one year.
Market Cap
602.71M
Enterprise Value
571.13M
Revenue
236.21M
Ranking
n/a
PE Ratio
8.96
Stock Price
49.05
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 602.71M, an increase of 13.02%. That is a compound annual growth rate of 0.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 602.71M | 20.25% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | 574.19M | 14.12% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.32B |
| Novartis AG | 200.48B |
| Lonza Group AG | 38.63B |
| Galderma Group AG | 37.98B |
| Alcon | 31.37B |
| Sandoz Group AG | 24.43B |
| Straumann Holding AG | 14.61B |
| Sonova Holding AG | 11.93B |